AIM ImmunoTech Inc. Common Stock (NY: AIM )
0.1290
-0.0096
(-6.93%)
Official Closing Price
Updated: 8:00 PM EST, Feb 14, 2025
Add to My Watchlist
Press Releases about AIM ImmunoTech Inc. Common Stock
![](https://www.businesswire.com/images/bwlogo_extreme.png)
AIM ImmunoTech Announces Election of Three Incumbent Board Members at Annual Meeting
December 17, 2024
From AIM ImmunoTech Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
AIM ImmunoTech Refutes Activist Group’s False and Misleading Claims
November 27, 2024
From AIM ImmunoTech Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
AIM ImmunoTech Announces Cash Conservation Plan
November 27, 2024
From AIM ImmunoTech Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20241104047141/en/2293010/5/AIM_Web_Graphic.jpg)
From AIM ImmunoTech Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From AIM ImmunoTech Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
AIM ImmunoTech Provides Update Regarding Annual Meeting
November 28, 2023
From AIM ImmunoTech Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231105960127/en/1935756/5/Activist_Group_Web_of_Interconnections.jpg)
From AIM ImmunoTech Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Rise in Biotech Innovations Generating Hope as Pancreatic Cancer Survival Rates Climb
March 14, 2023
Exposures
Product Safety
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://www.businesswire.com/images/bwlogo_extreme.png)
AIM ImmunoTech Announces Corporate Governance Enhancements
November 09, 2022
From AIM ImmunoTech Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
AIM ImmunoTech Board Issues Letter to Shareholders
October 26, 2022
From AIM ImmunoTech Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
AIM ImmunoTech Board Files Definitive Proxy Statement and Sends Letter to Shareholders
September 19, 2022
From AIM ImmunoTech Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From AIM ImmunoTech Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.